Pre-launch · We're opening Reserve Meds to a limited first cohort. Join the waitlist ›

Countries we serve

39 countries with established Named Patient Program or personal-import pathways.

East Asia

Hong Kong Japan South Korea Taiwan

Latin America

Argentina Brazil Chile Colombia Ecuador Mexico Peru

Middle East

Bahrain Jordan Kuwait Lebanon Oman Qatar Saudi Arabia United Arab Emirates

Middle East / Europe

North Africa

Oceania

Australia New Zealand

South Asia

Bangladesh India Nepal Pakistan Sri Lanka

Southeast Asia

Indonesia Malaysia Philippines Singapore Thailand Vietnam

Sub-Saharan Africa

Ethiopia Ghana Kenya Nigeria South Africa

Review & oversight. Content on this page is reviewed by Reserve Meds's clinical and regulatory team. A US-licensed pharmacist reviews every prescription before dispensing. Regulatory posture is informational, not legal advice; case-specific questions route to retained outside counsel. Review methodology ›
Last medically reviewed: 2026-04-22.